Search by Drug Name or NDC

    NDC 49702-0231-13 Triumeq 600; 50; 300 mg/1; mg/1; mg/1 Details

    Triumeq 600; 50; 300 mg/1; mg/1; mg/1

    Triumeq is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ViiV Healthcare Company. The primary component is ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE.

    Product Information

    NDC 49702-0231
    Product ID 49702-231_c6caf251-b34f-4846-a477-576354b96d15
    Associated GPIs 12109903150320
    GCN Sequence Number 072718
    GCN Sequence Number Description abacavir/dolutegravir/lamivudi TABLET 600-50-300 ORAL
    HIC3 W5Z
    HIC3 Description ANTIRETROVIRAL-NRTIS AND INTEGRASE INHIBITORS COMB
    GCN 36999
    HICL Sequence Number 041355
    HICL Sequence Number Description ABACAVIR SULFATE/DOLUTEGRAVIR SODIUM/LAMIVUDINE
    Brand/Generic Brand
    Proprietary Name Triumeq
    Proprietary Name Suffix n/a
    Non-Proprietary Name abacavir sulfate, dolutegravir sodium, lamivudine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 600; 50; 300
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
    Labeler Name ViiV Healthcare Company
    Pharmaceutical Class Cytochrome P450 1A1 Inhibitors [MoA], HIV Integrase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Human Immunodeficiency Virus Nucleosid
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA205551
    Listing Certified Through 2024-12-31

    Package

    NDC 49702-0231-13 (49702023113)

    NDC Package Code 49702-231-13
    Billing NDC 49702023113
    Package 30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13)
    Marketing Start Date 2014-08-22
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 108.085
    Pricing Unit EA
    Effective Date 2022-01-01
    NDC Description TRIUMEQ 600-50-300 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 2
    Classification for Rate Setting B
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis